Market Overview

Benzinga's Top #PreMarket Losers

Related GERN
Geron Mixed After Company Announces Start Of Phase 2/3 Clinical Trial
Piper Jaffray Sees Strength In Geron After News Of Drug Development
Related FRME
Monday's Mid-Day Movers: Greece's Bank Shuts Down; Puerto Rico Unable To Pay Debts
Morning Market Gainers

Geron (NASDAQ: GERN) shares fell 21.53% to $4.41 in the pre-market trading. Geron's PEG ratio is -3.94.

First Merchants (NASDAQ: FRME) dipped 7.01% to $19.50 in the pre-market session. First Merchants is expected to report its Q4 financial results on January 28, 2014.

GW Pharmaceuticals plc (NASDAQ: GWPH) dipped 4.11% to $47.13. GW Pharmaceuticals' trailing-twelve-month profit margin is -14.81%.

Vodafone Group Public Limited Company (NASDAQ: VOD) shares dropped 3.50% to $36.71 in pre-market trading. AT&T (NYSE: T) confirmed that it does not intend to make an offer for Vodafone.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (FRME + GERN)

Get Benzinga's Newsletters